Search

everythinglearnresearchcommunity

for

Search:↓

Hydrogel composites have great potential in regenerative medicine, tissue engineering, and drug delivery.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Customized medications made through compounding can be beneficial for various skin conditions but require careful regulation and collaboration between doctors and pharmacists.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

Eyelashes protect the eyes, but more research is needed to understand how.

Scientists have improved 3D models of human skin for research and medical uses, but still face challenges in perfectly replicating real skin.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

scINSIGHT accurately identifies cell clusters and gene patterns in complex data.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Effective treatment for hidradenitis suppurativa varies, with antibiotics commonly used and surgery as an option, but no single method is universally successful.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Somatostatin may help protect hair follicles from immune attacks.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Skin spheroids with both outer and inner layers are key for regrowing skin patterns and hair.

Biomimetic scaffolds are better than traditional methods for growing cells and could help regenerate various tissues.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Erdr1 could be a new marker for diagnosing hair loss.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Premature graying and hair changes can be treated with certain peptides and possibly targeting the endocannabinoid system.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

New treatments for hair growth disorders are needed due to limited current options and complex hair follicle biology.

New therapies show promise for wound healing, but more research is needed for safe, affordable options.